An official website of the United States government Here's how you know

The .gov means it's official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Drugs@FDA: FDA-Approved Drugs

Home | Previous Page

Biologic License Application (BLA): 125511
Company: NPS PHARMS INC

Medication Guide

REMS

Summary Review

Products on BLA 125511

Drug Name	Active Ingredients	Strength	Dosage Form/Route	Marketing Status	TE Code	RLD	RS
NATPARA	PARATHYROID HORMONE	25MCG	INJECTABLE;INJECTION	Prescription	TBD	TBD	No
NATPARA	PARATHYROID HORMONE	50MCG	INJECTABLE;INJECTION	Prescription	TBD	TBD	No
NATPARA	PARATHYROID HORMONE	75MCG	INJECTABLE;INJECTION	Prescription	TBD	TBD	No
NATPARA	PARATHYROID HORMONE	100MCG	INJECTABLE;INJECTION	Prescription	TBD	TBD	No

Approval Date(s) and History, Letters, Labels, Reviews for BLA 125511

Original Approvals or Tentative Approvals

Action Date	Submission	Action Type	Submission Classification	Review Priority; Orphan Status	Letters, Reviews, Labels, Patient Package Insert	Notes	Url
01/23/2015	ORIG-1	Approval		N/A; Orphan	Label (PDF) Letter (PDF) Review Summary Review (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2015/125511s000lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2015/125511Orig1s000ltr.pdf https://www.accessdata.fda.gov/drugsatfda_docs/nda/2015/125511Orig1s000TOC.cfm https://www.accessdata.fda.gov/drugsatfda_docs/nda/2015/125511Orig1s000SumR.pdf

Supplements

Action Date	Submission	Supplement Categories or Approval Type	Letters, Reviews, Labels, Patient Package Insert	Note	Url
04/07/2022	SUPPL-28	Supplement	Label (PDF) Letter (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/125511s028lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2022/125511Orig1s028ltr.pdf
06/05/2020	SUPPL-21	Supplement	Letter (PDF)	Label is not available on this site.	https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2020/125511Orig1s021ltr.pdf
07/01/2020	SUPPL-20	Supplement	Label (PDF) Letter (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/125511s020lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2020/125511Orig1s020replacementltr.pdf
12/17/2018	SUPPL-16	Supplement	Label (PDF) Letter (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/125511s016lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2018/125511Orig1s016ltr.pdf
09/27/2018	SUPPL-14	Supplement	Label (PDF) Letter (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/125511s014lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2018/125511Orig1s014ltr.pdf
06/15/2016	SUPPL-4	Supplement	Label (PDF) Letter (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2016/125511s004lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2016/125511Orig1s004ltr.pdf
09/29/2016	SUPPL-2	Supplement	Letter (PDF)	Label is not available on this site.	https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2016/125511Orig1s002ltr.pdf

Labels for BLA 125511

Action Date	Submission	Supplement Categories or Approval Type	Letters, Reviews, Labels, Patient Package Insert	Note	Url
04/07/2022	SUPPL-28	Labeling-Container/Carton Labels	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/125511s028lbl.pdf
04/07/2022	SUPPL-28	Labeling-Patient Package Insert	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/125511s028lbl.pdf
04/07/2022	SUPPL-28	Labeling-Package Insert	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/125511s028lbl.pdf
07/01/2020	SUPPL-20	Labeling-Package Insert	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/125511s020lbl.pdf
12/17/2018	SUPPL-16	Labeling-Medication Guide	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/125511s016lbl.pdf
09/27/2018	SUPPL-14	Labeling-Medication Guide	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/125511s014lbl.pdf
09/27/2018	SUPPL-14	Labeling-Package Insert	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/125511s014lbl.pdf
06/15/2016	SUPPL-4	Labeling-Package Insert	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2016/125511s004lbl.pdf
01/23/2015	ORIG-1	Approval	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2015/125511s000lbl.pdf

Therapeutic Equivalents for BLA 125511

NATPARA

There are no Therapeutic Equivalents.

Top